ImmuPharma celebrates "significant milestone" for P140 platform
(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform. Read More
Price | 2.44p on 15-04-2025 | at 05:00:04
---|---|
Change | 0.00p 0% |
Buy | 0.00p |
Sell | 0.00p |
Buy / Sell IMM Shares |
Last Trade: | Sell 34,549.00 at 2.3028p |
Day's Volume: | 0 |
Last Close: | 2.44p |
Open: | 0.00p |
ISIN: | GB0033711010 |
Day's Range | 0.00p - 0.00p |
52wk Range: | 0.85p - 7.26p |
Market Capitalisation: | £10m |
VWAP: | 0.00p |
Shares in Issue: | 416m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Immupharma (IMM) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 34,549 | 2.3028p | Ordinary |
14:53:35 - 14-Apr-25 |
Sell* | 5,000 | 2.3062p | Ordinary |
14:24:39 - 14-Apr-25 |
Buy* | 37,476 | 2.495p | Ordinary |
14:21:32 - 14-Apr-25 |
Buy* | 86 | 2.58p | SI Trade |
14:16:46 - 14-Apr-25 |
Sell* | 75,000 | 2.40p | Automatic Execution |
14:16:46 - 14-Apr-25 |
Sell* | 54,184 | 2.4042p | Ordinary |
14:14:30 - 14-Apr-25 |
Buy* | 197 | 2.526p | Ordinary |
14:01:23 - 14-Apr-25 |
Sell* | 4,326 | 2.404p | Ordinary |
13:51:25 - 14-Apr-25 |
Sell* | 53,000 | 2.45p | Ordinary |
13:25:13 - 14-Apr-25 |
Sell* | 10,000 | 2.40p | Ordinary |
13:07:16 - 14-Apr-25 |
Immupharma (IMM) Regulatory News |
||
Date | Source | Headline |
---|---|---|
1st Apr 2025 7:00 am | RNS | Warrant Extension, Debt Conversion & Equity Issue |
1st Apr 2025 7:00 am | RNS | Extension of Warrants in Incanthera to 30 Sep 2025 |
14th Mar 2025 7:00 am | RNS-R | IMM attending Bio-Europe Spring 17-19 March,Milan |
13th Mar 2025 7:00 am | RNS | ImmuPharma proves unique Mechanism of Action-P140 |
21st Feb 2025 11:36 am | RNS | Holding(s) in Company |
13th Feb 2025 7:00 am | RNS | £2.91m fundraising; related party transactions |
28th Jan 2025 12:57 pm | RNS | Response to Share Price Movement |
9th Jan 2025 7:00 am | RNS | Breakthrough Findings into Autoimmune Diseases |
23rd Dec 2024 7:00 am | RNS | Change of Auditor |
10th Dec 2024 2:36 pm | RNS | Holding(s) in Company |